Nektar Small Molecule PEGylation programs highlighted in the March 2008 issue of R&D Directions.
more
June 2, 2008 Presentation by Lead Clinical Investigator for NKTR-102 during ASCO 2008 Listen to Webcast
June 2, 2008Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan) June 2, 2008New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Molecule PEG-Oncolytics
Cimzia® approved in the U.S. for Crohn’s Disease more
Positive Phase 2 Data Presented for NKTR-061 at American Thoracic Society Meeting in Toronto more
Listen to Webcast
